Table 7.
Treatment Group | ||
---|---|---|
Suspected Adverse Drug Reactions | Pimobendan | Placebo |
Gastrointestinal disorders (eg, emesis, diarrhea, inappetence) | 6 | 3 |
Abnormal behavior (eg, lethargy, confusion, restlessness) | 1 | 2 |
Head bobbing (transient) after administration of mexiletine, condition resolved | 1 | |
Increased respiratory rate and effort with exercise | 1 | |
Cough (unexplained cause) | 1 | |
Mast cell tumor, left thorax | 1 | |
Pulmonary mass and rectal mass | 1 | |
Ventricular arrhythmia on Holter monitor recording | 1 | |
Irregular and rapid heartbeats reported by owner | 1 | |
Syncope | 4 | |
Total | 9 | 14 |